The loss of FasL expression on sEVs in advanced disease might represent the downregulation of the apoptosis signaling pathways by the tumor cells as a matter of tumor resistance and the upregulation of Fas suggests the recovering immune system after successful therapy. Here, FAS is linked to neoplasm.